Key result
Percutaneous pulmonary valve implantation using the Venus P-valve was successful in 37 of 38 procedures with no valve failure at 25 months, though frame fractures occurred in 27% of patients.
Why the study?
The study was conducted to evaluate the international procedural and short-term to midterm experience with the new percutaneous Venus P-valve.
Does percutaneous pulmonary valve implantation using the Venus P-valve improve pulmonary regurgitation and right ventricular volumes in patients requiring pulmonary valve replacement?
Observational (n=38)
Yes
Does percutaneous pulmonary valve implantation using the Venus P-valve improve pulmonary regurgitation and right ventricular volumes in patients requiring pulmonary valve replacement?
The Venus P-valve provides satisfactory midterm results with high procedural success and significant improvements in pulmonary regurgitation and right ventricular volumes, despite a 27% incidence of frame fractures.
No takes yet. Share an insight, caveat, or question.
Supports Venus P-valve feasibility in observational data; leaves open durability and fracture risks pending prospective trials.
Morgan et al. (2019) conducted an observational in Pulmonary valve disease requiring implantation (n=38). Venus P-valve was evaluated on Procedural success, valve performance, and complications. Percutaneous pulmonary valve implantation using the Venus P-valve was successful in 37 of 38 procedures with no valve failure at 25 months, though frame fractures occurred in 27% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: